Europe Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian)

Code: TIPRE00010241 | Pages: 145 | Industry: Pharmaceuticals | Date: Apr 2022 | Type: Regional

The biopharmaceutical contract manufacturing market in Europe is expected to grow from US$ 4,610.37 million in 2021 to US$ 8,026.13 million by 2028; it is estimated to register a CAGR of 8.2% from 2021 to 2028.

 

The contract manufacturing market for biologics is growing at an unprecedented rate due to increasing biologics pipeline, manufacturing complexity, and companies shifting their focus toward core activities. Many pharmaceutical & biotechnology companies outsource varied services, such as early-stage drug development and commercial-scale manufacturing. Outsourcing is required to expedite research & development, speed up market entry, give access to novel technologies, provide regulatory expertise, and reduce risks at a competitive cost. Complexities in biologics development & production and increasingly stringent quality standards have driven drug manufacturers to prefer contract manufacturer services. The demand for contract manufacturing of biologics increased due to difficulties faced in producing large-scale biologics in-house. The production will increase after the approval of novel technologies, such as manufacturing CAR-T therapy. With more biological products and biosimilars entering the market, the competition is rising within the biopharmaceutical sector. Biologics manufacturers strive to reduce manufacturing costs, deliver high-quality drugs, improve process efficiency, and accelerate market entry. CMOs can adopt as per requirements and help in the innovation process and improve operational efficiency. As the pharmaceutical industry is shifting from large-scale production to niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations are offering significant advantages to contract manufacturing organizations (CMOs). Moreover, many companies are opting for CMOs services to speed up the development process and lower production costs, leading to the biopharmaceutical contract manufacturing market growth.

 

Europe Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

Europe Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


Europe Biopharmaceutical Contract Manufacturing Market Segmentation     

 

Europe Biopharmaceutical Contract Manufacturing Market – By Product

  • Biologics
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Others
  • Biosimilar

 

 

Europe Biopharmaceutical Contract Manufacturing Market – By Service

  • Process Development
    • Downstream Processing
    • Upstream Processing
  • Fill and Finish Operation
  • Analytical and QC Studies
  • Packaging

 

Europe Biopharmaceutical Contract Manufacturing Market – By Source

  • Mammalian
  • Microbial-Based Biologics/ Non-Mammalian

 

Europe Biopharmaceutical Contract Manufacturing Market– By Country

  • Germany
  • France
  • The UK
  • Italy
  • Spain
  • The Rest of Europe

Europe Biopharmaceutical Contract Manufacturing Market-Companies Mentioned

  • AbbVie Inc.
  • Ajinomoto Co. Inc
  • Boehringer Ingelheim International GmbH
  • General Electric Company
  • Lonza
  • MERCK KGAA
  • Samsung Biologics
  • THERMO FISHER SCIENTIFIC INC
  • WUXI BIOLOGICS

 

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Biopharmaceutical Contract Manufacturing Market – By Product

1.3.2        Europe Biopharmaceutical Contract Manufacturing Market – By Service

1.3.3        Europe Biopharmaceutical Contract Manufacturing Market – By Source

1.3.4        Europe Biopharmaceutical Contract Manufacturing Market – By Country

2.           Europe Biopharmaceutical Contract Manufacturing Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Biopharmaceutical Contract Manufacturing – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe – PEST Analysis

4.3         Expert Opinion

5.           Europe Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Outsourcing by Pharmaceutical Companies

5.1.2        Increasing Demand for Biologics

5.2         Market Restraints

5.2.1        Increasing Competition in Industry

5.3         Future Trends

5.3.1        Consolidation in Pharmaceutical CMO Industry

5.3.2        COVID-19 Pandemic

5.4         Impact Analysis

6.           Biopharmaceutical Contract Manufacturing Market – Europe Analysis

6.1         Europe Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis

7.           Europe Biopharmaceuticals Contract Manufacturing Market Analysis – By Product

7.1         Overview

7.2         Europe Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

7.3         Biologics

7.3.1        Overview

7.3.2        Biologics: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Monoclonal Antibodies

7.3.2.1.1          Overview

7.3.2.1.2          Monoclonal Antibodies: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Recombinant Proteins

7.3.2.2.1          Overview

7.3.2.2.2          Recombinant Proteins: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Vaccines

7.3.2.3.1          Overview

7.3.2.3.2          Vaccines: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4          Others

7.3.2.4.1          Overview

7.3.2.4.2          Others: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Biosimilar

7.4.1        Overview

7.4.2        Biosimilar: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Biopharmaceuticals Contract Manufacturing Market – By Service

8.1         Overview

8.2         Europe Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

8.3         Process Development

8.3.1        Overview

8.3.2        Process Development: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Downstream Processing

8.3.2.1.1          Overview

8.3.2.1.2          Downstream Processing: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Upstream Processing

8.3.2.2.1          Overview

8.3.2.2.2          Upstream Processing: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Fill and Finish Operations

8.4.1        Overview

8.4.2        Fill and Finish Operations: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Analytical and QC Studies

8.5.1        Overview

8.5.2        Analytical and QC Studies: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Packaging

8.6.1        Overview

8.6.2        Packaging: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Biopharmaceuticals Contract Manufacturing Market – By Source

9.1         Overview

9.2         Europe Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

9.3         Mammalian

9.3.1        Overview

9.3.2        Mammalian: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Microbial/Non-Mammalian-Based Biologics

9.4.1        Overview

9.4.2        Microbial/Non-Mammalian-Based Biologics: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Biopharmaceutical Contract Manufacturing Market – Country Analysis

10.1      Europe: Biopharmaceutical Contract Manufacturing Market

10.1.1     Overview

10.1.3     Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.1.3.1       Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1.1       Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1.2       Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.1.2.1     Germany: Biologics Market, 2019-2028 (USD Million)

10.1.3.1.3       Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.1.3.1     Germany: Process Development Market, 2019-2028 (USD Million)

10.1.3.1.4       Germany: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.2       UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1       UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.2       UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.2.2.1     UK: Biologics Market, 2019-2028 (USD Million)

10.1.3.2.3       UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.2.3.1     UK: Process Development Market, 2019-2028 (USD Million)

10.1.3.2.4       UK: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.3       France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.3.1       France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.3.2       France: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.3.2.1     France: Biologics Market, 2019-2028 (USD Million)

10.1.3.3.3       France: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.3.3.1     France: Process Development Market, 2019-2028 (USD Million)

10.1.3.3.4       France: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.4       Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.4.1       Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.4.2       Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.4.2.1     Spain: Biologics Market, 2019-2028 (USD Million)

10.1.3.4.3       Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.4.3.1     Spain: Process Development Market, 2019-2028 (USD Million)

10.1.3.4.4       Spain: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.5       Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.5.1       Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.5.2       Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.5.2.1     Italy: Biologics Market, 2019-2028 (USD Million)

10.1.3.5.3       Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.5.3.1     Italy: Process Development Market, 2019-2028 (USD Million)

10.1.3.5.4       Italy: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.6       Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.6.1       Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.6.2       Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.6.2.1     Rest of Europe: Biologics Market, 2019-2028 (USD Million)

10.1.3.6.3       Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.6.3.1     Rest of Europe: Process Development Market, 2019-2028 (USD Million)

10.1.3.6.4       Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

11.        Europe Biopharmaceutical Contract Manufacturing Market – Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      THERMO FISHER SCIENTIFIC INC.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      General Electric Company

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      MERCK KGAA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Lonza

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Samsung Biologics

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      AbbVie Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      WUXI BIOLOGICS

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Ajinomoto Co. Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Europe Biopharmaceutical Contract Manufacturing Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 4.             Germany Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 5.             Germany Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 6.             Germany Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 7.             UK Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 8.             UK Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 9.             UK Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 10.          UK Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 11.          UK Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 12.          France Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 13.          France Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 14.          France Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 15.          France Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 16.          France Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 17.          Spain Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 18.          Spain Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 19.          Spain Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 20.          Spain Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 21.          Spain Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 22.          Italy Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 23.          Italy Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 24.          Italy Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 25.          Italy Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 26.          Italy Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 27.          Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 28.          Rest of Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 31.          Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 32.          Organic Developments Done By Companies

Table 33.          Inorganic Developments Done By Companies

Table 34.          Glossary of Terms, Europe Biopharmaceutical Contract Manufacturing Market

 

 

LIST OF FIGURES

Figure 1.           Europe Biopharmaceutical Contract Manufacturing Market Segmentation

Figure 2.           Europe Biopharmaceutical Contract Manufacturing Segmentation, By Country

Figure 3.           Europe Biopharmaceutical Contract Manufacturing Market Overview

Figure 4.           Biologics Segment Held Largest Share Of Product In Europe Biopharmaceutical Contract Manufacturing Market

Figure 5.           Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe PEST Analysis

Figure 7.           Europe Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints

Figure 8.           Europe Biopharmaceutical Contract Manufacturing Market – Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           Europe Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

Figure 10.        Biologics: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Monoclonal Antibodies: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Recombinant Proteins: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Vaccines: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Others: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Biosimilar: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

Figure 17.        Process Development: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Downstream Processing: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Upstream Processing: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Fill and Finish Operations: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Analytical and QC Studies: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Packaging: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

Figure 24.        Mammalian: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Microbial/Non-Mammalian-Based Biologics: Europe Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

Figure 27.        Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

Figure 28.        Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

  1. AbbVie Inc.
  2. Ajinomoto Co. Inc
  3. Boehringer Ingelheim International GmbH
  4. General Electric Company
  5. Lonza
  6. MERCK KGAA
  7. Samsung Biologics
  8. THERMO FISHER SCIENTIFIC INC
  9. WUXI BIOLOGICS
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000